| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 62,447 | 77,169 | 48,071 | 43,406 | | Cost of Revenue | 38,765 | 47,883 | 28,709 | 26,089 | | | Gross Profit | 23,682 | 29,286 | 19,362 | 17,317 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 13,529 | 16,365 | 10,244 | 9,919 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 323 | 322 | 311 | 186 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 9,830 | 12,599 | 8,806 | 7,213 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 59 | 63 | 195 | 269 | | Earnings Before Interest And Taxes | 9,889 | 12,662 | 9,002 | 7,482 | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | 9,889 | 12,662 | 9,002 | 7,482 | | Income Tax Expense | 3,624 | 4,587 | 3,352 | 2,597 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 6,265 | 8,075 | 5,649 | 4,885 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 6,265 | 8,075 | 5,649 | 4,885 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $6,265 | $8,075 | $5,649 | $4,885 |
|
0.20% Nasdaq 
Income Statement
